Related Experiment Video

Updated: May 12, 2026

Development and Application of Rapamycin-regulated Tyrosine Phosphatases
06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas

Venera Cardile1, Grazia Malaponte, Carla Loreto

  • 1Department of Bio-medical Sciences, Section of Physiology, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.

Acta Histochemica
|April 23, 2013
PubMed

Insights

Down-regulation of Raf-1 kinase inhibitor protein (RKIP) and its phosphorylated form (pRKIP) correlates with melanoma metastasis. Analyzing RKIP and pRKIP levels may help distinguish metastatic from non-metastatic melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Melanoma is a skin cancer known for its high metastatic potential.
  • Raf-1 kinase inhibitor protein (RKIP) regulates the Ras/Raf/MEK/ERK signaling pathway, crucial in cell proliferation and survival.
  • Understanding RKIP and pRKIP expression in melanoma progression is vital for prognostic insights.

Purpose of the Study:

  • To investigate the expression patterns of RKIP and its phosphorylated form (pRKIP) in various stages of melanoma.
  • To determine the correlation between RKIP/pRKIP expression and the metastatic potential of melanoma cells.
  • To explore the potential of RKIP and pRKIP as biomarkers for melanoma progression.

Main Methods:

  • Immunohistochemistry was used to evaluate RKIP and pRKIP protein expression in control skin, nevi, and melanomas.
  • Western blotting was performed on normal melanocytes and melanoma cell lines (WM35, A375, M14, A2058).
  • Expression levels were analyzed in relation to melanoma stage and metastatic ability.

Main Results:

  • A significant correlation was observed between RKIP and pRKIP expression levels and the metastatic capacity of melanoma cells.
  • Down-regulation of both RKIP and pRKIP was associated with metastatic melanoma.
  • Low RKIP and high pRKIP expression may indicate non-metastatic melanoma, particularly in Clark's levels I and II.

Conclusions:

  • RKIP and pRKIP expression levels show a negative correlation with metastasis in melanoma.
  • These proteins may serve as valuable prognostic markers for human cutaneous melanoma progression.
  • Investigating RKIP and pRKIP could offer a useful tool for differentiating metastatic from non-metastatic melanoma across different Clark's levels.
Keywords:
Cancer markerMelanomaMetastasisRKIPpRKIP

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...